Latent Tuberculosis Infection Treatment: Compliance and Factors Related with Initiation
Arch Bronconeumol. 2023 May;59(5):334-336.
doi: 10.1016/j.arbres.2022.12.011.
Epub 2022 Dec 23.
[Article in
English,
Spanish]
Affiliations
- 1 Pneumology, University Hospital San Agustín, Avilés, Spain; Integrated Tuberculosis and NMT Research Program (PII-TB &NMT), Spain. Electronic address: josegubl@gmail.com.
- 2 Integrated Tuberculosis and NMT Research Program (PII-TB &NMT), Spain.
- 3 Pneumology, University Hospital San Agustín, Avilés, Spain; Integrated Tuberculosis and NMT Research Program (PII-TB &NMT), Spain.
- 4 Integrated Tuberculosis and NMT Research Program (PII-TB &NMT), Spain; Pneumology, University Hospital of Cruces, Baracaldo, Spain.
- 5 Integrated Tuberculosis and NMT Research Program (PII-TB &NMT), Spain; Pneumology, University Hospital Moisés Broggi, Sant Joan Despí, Spain.
No abstract available
MeSH terms
-
Antitubercular Agents / therapeutic use
-
Humans
-
Latent Tuberculosis* / drug therapy
-
Patient Compliance
-
Tuberculin Test